Evidence map›Paper›PMID 40503919›Full record

ArticleJournal of synchrotron radiation2025

AF4-to-SAXS: expanded characterization of nanoparticles and proteins at the P12 BioSAXS beamline.

Stefano Da Vela, Kim Bartels, Daniel Franke, Dymtro Soloviov, Tobias Gräwert, Dmitry Molodenskiy, Bastian Kolb, Christoph Wilhelmy, Roland Drexel, Florian Meier and 3 more

Abstract read
In one paragraph

Article in Journal of synchrotron radiation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Stefano Da VelaEuropean Molecular Biology Laboratory, Hamburg Unit, Hamburg, Germany.ORCID 0000-0002-1700-4759
Kim BartelsDepartment of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg University, Mainz, Germany.ORCID 0000-0002-7980-1913
Daniel FrankeBIOSAXS GmbH, Hamburg, Germany.
Dymtro SoloviovEuropean Molecular Biology Laboratory, Hamburg Unit, Hamburg, Germany.ORCID 0000-0001-7945-2218
Tobias GräwertBIOSAXS GmbH, Hamburg, Germany.ORCID 0000-0001-9983-5718
Dmitry MolodenskiyEuropean Molecular Biology Laboratory, Hamburg Unit, Hamburg, Germany.ORCID 0000-0002-5954-4294
Bastian KolbDepartment of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg University, Mainz, Germany.
Christoph WilhelmyDepartment of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg University, Mainz, Germany.
Roland DrexelPostnova Analytics GmbH, Landsberg am Lech, Germany.
Florian MeierPostnova Analytics GmbH, Landsberg am Lech, Germany.
Heinrich HaasDepartment of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg University, Mainz, Germany.ORCID 0000-0002-5517-5970
Peter LangguthDepartment of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg University, Mainz, Germany.
Melissa A GraewertEuropean Molecular Biology Laboratory, Hamburg Unit, Hamburg, Germany.ORCID 0000-0001-7547-636X

Funding

Bundesministerium für Bildung und Forschung 05K22UM3European Molecular Biology Laboratory ERI
6 · The paper itself

Abstract

Biological small-angle X-ray scattering (SAXS) is a versatile and powerful technique for investigating the structural and biophysical properties of biologically and pharmaceutically relevant macromolecules and nanoparticles. SAXS offers detailed insights into macromolecular composition, size, shape and internal structure, while addressing key aspects such as oligomeric state, stability, molecular interactions, and conformational flexibility. Recently, asymmetrical-flow field-flow fractionation (AF4) was successfully coupled to SAXS, enabling online size-based fractionation and analysis of polydisperse samples. This approach allows precise, size-dependent characterization, offering significant advancements in the study of polydisperse systems. We have integrated an AF4 device at the P12 beamline at the European Molecular Biology Laboratory and implemented technical adaptations allowing full automation to make the system suitable for routine user access. We provide streamlined workflows and troubleshooting resources for both novice and advanced SAXS users thereby equipping them with clear guidance on performing AF4-SAXS measurements. The general principles of our set-up are easily adaptable to other beamlines which have integrated (or are planning to integrate) a similar system.

Indexed as

Fractionation, Field FlowNanoparticlesProteinsScattering, Small AngleX-Ray DiffractionSynchrotronsProteinsAF4biological SAXSfull automationnanoparticlesoperator-friendly guidelinesP12 beamlineproteins

Identifiers

PMID40503919
PMCPMC12236253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.